Press Releases Insulet Corporation

Equities

PODD

US45784P1012

Real-time Estimate Cboe BZX Other stock markets 02:37:54 2024-06-10 pm EDT			5-day change	1st Jan Change
190.1 ^USD	-0.71%		+5.06%	-12.16%

Jun. 06	Transcript : Insulet Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM
May. 30	Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insulet : 2023 Conflict Minerals Policy	May. 28	PU
Insulet to Present at the Jefferies Global Healthcare Conference	May. 28	BU
Preliminarily Enjoin Alleged Trade Secret Misappropriation Without Addressing A Time Bar Defense Under The DTSA?	May. 21	AQ
Insulet: Q1 Earnings Snapshot	May. 09	AQ
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year	May. 09	BU
Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth	May. 07	BU
Insulet : 2023 ESG Data	May. 06	PU
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024	Apr. 03	BU
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer	Mar. 20	BU
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy	Mar. 08	BU
Insulet to Present Results from First Omnipod 5 Randomized Controlled Trial at the 17th International Conference on Advanced Technologies and Treatments for Diabetes	Mar. 06	AQ
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	Mar. 05	BU
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024	Feb. 23	AQ
Insulet: Q4 Earnings Snapshot	Feb. 22	AQ
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)	Feb. 22	BU
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference	Feb. 13	BU
Insulet Announces CE Mark Approval of Omnipod 5 Integration with Abbott FreeStyle Libre 2 plus Sensor	Feb. 08	AQ
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor	Feb. 07	BU
Imperative Care Announces Four Senior Leadership Appointments	Jan. 30	AQ
Insulet Announces Changes to Board of Directors with Retirements and New Appointments	Jan. 18	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Insulet Corporation

Equities

PODD

US45784P1012

Press Releases

Filters